Thermo Fisher Scientific Inc.
Every calculator, already run for TMO
Open the full toolkit →You have the numbers on TMO. Get the argument.
A written report on which of these readings actually decide the outcome for Thermo Fisher Scientific Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
29 analysts covering TMOAnalyst Price Target Disagreement for Thermo Fisher Scientific Inc.
Wall Street's bull case implies +15% from the current price; the bear case implies -20%. A 35% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for TMO
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environme…
TMO — frequently asked
Is TMO a buy right now?
Wall Street's consensus rating on Thermo Fisher Scientific Inc. is Buy across 29 analysts, with a mean price target of $645.15 (-1% vs. the current $651.45). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is TMO overvalued?
TMO trades at 35.1x trailing earnings, against a DCF fair value of $421 per share. The current price implies 12% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is TMO's next earnings date?
Thermo Fisher Scientific Inc. is next scheduled to report earnings around Oct 21, 2026. A full TMO research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Thermo Fisher Scientific Inc.?
Analysts covering Thermo Fisher Scientific Inc. (TMO) range from a bear-case target of $520.00 to a bull-case high of $750.00, with a mean consensus target of $645.15 across 27 analysts. The spread of $230.00 (35% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Thermo Fisher Scientific Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Thermo Fisher Scientific Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full TMO research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Thermo Fisher Scientific Inc., in minutes. 3 free reports included with every account — no credit card required.